These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 792424)

  • 1. An approach to a molecular understanding of exocytotic insulin release.
    Lazarus NR; Davis B; O'Connor KJ
    J Physiol (Paris); 1976 Nov; 72(6):787-94. PubMed ID: 792424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Some events at the islet cell plasma membrane that may be associated with exocytotic insulin release.
    Lazarus NR; Davis B
    Symp Soc Exp Biol; 1979; 33():299-321. PubMed ID: 392793
    [No Abstract]   [Full Text] [Related]  

  • 3. An in vitro system for studying insulin release: effects of glucose and glucose-6-phosphate.
    Davis B; Lazarus NR
    J Physiol; 1977 Sep; 271(1):273-88. PubMed ID: 335048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An in Vitro system for studying insulin release caused by secretory granules-plasma membrane interaction: definition of the system.
    Davis B; Lazarus NR
    J Physiol; 1976 Apr; 256(3):709-29. PubMed ID: 178856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucoreceptor mechanisms in islets of Langerhans.
    Matschinsky FM; Landgraf R; Ellerman J; Kotler-Brajtburg J
    Diabetes; 1972; 21(2 Suppl):555-69. PubMed ID: 4559920
    [No Abstract]   [Full Text] [Related]  

  • 6. The pancreatic -cell recognition of insulin secretagogues. II. Site of action of tolbutamide.
    Hellman B; Sehlin J; Töljedal IB
    Biochem Biophys Res Commun; 1971 Dec; 45(6):1384-8. PubMed ID: 4942728
    [No Abstract]   [Full Text] [Related]  

  • 7. Insulin-like growth factor II inhibits glucose-induced insulin exocytosis.
    Zhang Q; Berggren PO; Larsson O; Hall K; Tally M
    Biochem Biophys Res Commun; 1998 Feb; 243(1):117-21. PubMed ID: 9473490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose regulation of insulin secretion independent of the opening or closure of adenosine triphosphate-sensitive K+ channels in beta cells.
    Sato Y; Anello M; Henquin JC
    Endocrinology; 1999 May; 140(5):2252-7. PubMed ID: 10218978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations of insulin secretion from mouse islets treated with sulphonylureas: perturbations of Ca2+ regulation prevail over changes in insulin content.
    Anello M; Gilon P; Henquin JC
    Br J Pharmacol; 1999 Aug; 127(8):1883-91. PubMed ID: 10482920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin secretion from isolated rat islets induced by the novel hypoglycemic agent A-4166, a derivative of D-phenylalanine.
    Tsukuda K; Sakurada M; Niki I; Oka Y; Kikuchi M
    Horm Metab Res; 1998 Jan; 30(1):42-9. PubMed ID: 9503038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatostatin inhibition of glucose-, tolbutamide-, theophylline, cytochalasin B-, and calcium-stimulated insulin release in monolayer cultures of rat endocrine pancreas.
    Fujimoto WY
    Endocrinology; 1975 Dec; 97(6):1494-500. PubMed ID: 1107017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of amino acids on insulin release from excised rabbit pancreas.
    Edgar P; Rabinowitz D; Merimee TJ
    Endocrinology; 1969 Apr; 84(4):835-43. PubMed ID: 4885795
    [No Abstract]   [Full Text] [Related]  

  • 13. Glucoreceptor mechanisms and the control of insulin release and biosynthesis.
    Ashcroft SJ
    Diabetologia; 1980 Jan; 18(1):5-15. PubMed ID: 6245006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glyburide and tolbutamide induce desensitization of insulin release in rat pancreatic islets by different mechanisms.
    Rabuazzo AM; Buscema M; Vinci C; Caltabiano V; Vetri M; Forte F; Vigneri R; Purrello F
    Endocrinology; 1992 Oct; 131(4):1815-20. PubMed ID: 1396327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of tetracycline and diazepam on insulin secretion and adenylyl cyclase activity of isolated rat islets of Langerhans.
    El-Denshary ES; Ismail NA; Montague W
    Diabete Metab; 1977 Mar; 3(1):3-6. PubMed ID: 323087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct glucocorticoid inhibition of insulin secretion. An in vitro study of dexamethasone effects in mouse islets.
    Lambillotte C; Gilon P; Henquin JC
    J Clin Invest; 1997 Feb; 99(3):414-23. PubMed ID: 9022074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual mechanism of the potentiation by glucose of insulin secretion induced by arginine and tolbutamide in mouse islets.
    Ishiyama N; Ravier MA; Henquin JC
    Am J Physiol Endocrinol Metab; 2006 Mar; 290(3):E540-9. PubMed ID: 16249257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and release of proinsulin and insulin by isolated rat islets of Langerhans.
    Tanese T; Lazarus NR; Devrim S; Recant L
    J Clin Invest; 1970 Jul; 49(7):1394-404. PubMed ID: 4914679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of increasing concentrations of glucose on insulin secretion. Synergy between glucose and hypoglycemic sulfonamides].
    Loubatières A; Mariani MM; Chapal J
    C R Seances Soc Biol Fil; 1968; 162(8):1575-80. PubMed ID: 4238184
    [No Abstract]   [Full Text] [Related]  

  • 20. Phosphoinositide hydrolysis and insulin secretion in response to glucose stimulation are impaired in isolated rat islets by prolonged exposure to the sulfonylurea tolbutamide.
    Zawalich WS
    Endocrinology; 1989 Jul; 125(1):281-6. PubMed ID: 2544404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.